ETF Managers Group, LLC Novavax Inc Transaction History

ETF Managers Group, LLC

$2.78 Billion
Q1 2023

A detailed history of ETF Managers Group, LLC transactions in Novavax Inc stock. As of the latest transaction made, ETF Managers Group, LLC holds 28,610 shares of NVAX stock, worth $266,645. This represents 0.01% of its overall portfolio holdings.

Number of Shares

28,610

Previous 19,572 46.18%

Holding current value

$266,645

Previous $201,000 1.49%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$5.76 - $12.48 $52,058 - $112,794	9,038 Added 46.18%	28,610 $198,000
Q4 2022 Mar 23, 2023	SELL	$8.86 - $25.04 $954,018 - $2.7 Million	-107,677 Reduced 84.62%	19,572 $201,000
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $1.99 Million - $8.31 Million	109,153 Added 603.19%	127,249 $2.32 Million
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $62,728 - $130,176	1,729 Added 10.56%	18,096 $938,000
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $225,994 - $463,138	3,241 Added 24.69%	16,367 $1.22 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $427,631 - $692,708	-3,178 Reduced 19.49%	13,126 $2.03 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $806,323 - $1.23 Million	-4,535 Reduced 21.76%	16,304 $3.32 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $732,655 - $1.56 Million	6,055 Added 40.96%	20,839 $4.35 Million
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $664,661 - $1.88 Million	-5,883 Reduced 28.47%	14,784 $2.56 Million
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $897,872 - $1.59 Million	-11,403 Reduced 35.56%	20,667 $2.46 Million
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $993,238 - $2.23 Million	12,503 Added 63.9%	32,070 $3.46 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $271,198 - $1.64 Million	19,567 New	19,567 $1.64 Million

Others Institutions Holding NVAX

# of Institutions

289

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $729M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Account

ETF Managers Group, LLC Novavax Inc Transaction History